Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma

Overview of attention for article published in Current Hematologic Malignancy Reports, October 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 16,281 followers.

Anti-CD19 CAR-T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma @huntsmancancer https://t.co/alNCbUbfLO

04 Nov 2018

Reply Repost Favourite

Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma. #lymphoma #lymsm https://t.co/pI1fQ7fT2t

27 Oct 2018

Reply Repost Favourite